首页> 外文期刊>American journal of medical genetics, Part A >Four children with postnatally diagnosed mosaic trisomy 12: Clinical features, literature review, and current diagnostic capabilities of genetic testing
【24h】

Four children with postnatally diagnosed mosaic trisomy 12: Clinical features, literature review, and current diagnostic capabilities of genetic testing

机译:患有出现后诊断的马赛克三术12:临床特征,文献综述以及遗传检测的当前诊断能力

获取原文
获取原文并翻译 | 示例
           

摘要

Children or adults with mosaic trisomy 12 diagnosed postnatally are extremely rare. Only a small number of patients with this mosaicism have been reported in the literature. The clinical manifestation of mosaic trisomy 12 is variable, ranging from mild developmental delay to severe congenital anomaly and neonatal death. The trisomy 12 cells are not usually able to be detected by phytohemagglutinin stimulated peripheral blood chromosome analysis. The variability of phenotypes and the limited number of patients with this anomaly pose a challenge to predict the clinical outcomes. In this study, we present the phenotypes and laboratory findings in four patients and review the 11 previously reported patients with mosaic trisomy 12 diagnosed postnatally, as well as 11 patients with mosaic trisomy 12 diagnosed prenatally. The findings of this study provide useful information for laboratory diagnosis and clinical management of these patients.
机译:出版后诊断的儿童或成年人有诊断的运动。 在文献中仅报道了少数患有这种马赛族的患者。 马赛克三元体12的临床表现是可变的,从轻度发育延迟到严重先天性异常和新生儿死亡。 通常可以通过植物血小霉素刺激外周血染色体分析来检测三胞12个细胞。 表型的变异性和有限数量的这种异常患者构成了预测临床结果的挑战。 在这项研究中,我们介绍了四个患者的表型和实验室发现,并审查了11例先前报道的患有后期诊断的马赛克三胞12患者的患者,以及11例MORAIC三术12患者。 本研究的调查结果为这些患者的实验室诊断和临床管理提供了有用的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号